glp-1 receptor agonists effects on cardiovascular risk reduction for the of Atherosclerotic in Patients With Type 2 Diabetes Frontiers | Glucagon-like peptide-1 receptor

doi: 10.1001/jamanetworkopen.2024.57349 114 ArvanitakisKKoufakisTPopovicDMalteseGMustafaODoumasMet al

Both acute GLP-1 infusion (65, 66) and a single liraglutide dose (67) decreased plasma ANG II concentration in healthy subjects and type 2 diabetic patients, consistently with an inhibitory effect of GLP-1 on renin secretion (68, 69)

doi: 10.1080/17512433.2017.1292125 157 FrssingSNylanderMChabanovaEFrystykJHolstJJKistorpCet al

Book a FREE 15-Minute Rapid Nutrition Assessment: Join our Facebook community for live Q&As & support Let's connect

K.BaldoB

There is still a negative deflection for 9/12mg arms suggesting we have not reached max reduction in A1c and keep in mind this is retatrutide alone, with no other medications allowed